EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

159P Unveiling the impact of DC vaccination on systemic immunity in advanced malignant melanoma: Preliminary results from the ABSIDE study

G.N. Sabatino, D. Fanelli, M. Cocchioni, C. Piccinini, F. De Rosa, M. Guidoboni, A.M. Granato, E. Pancisi, S. Carloni, I. Azzali, L. Renzi, V. Ancarani und 3 weitere

Immuno-Oncology and Technology · 2024-12 · 24 · 100788

DOI: 10.1016/j.iotech.2024.100788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immuno-Oncology and Technology, 2024-12. Verfasst von G.N. Sabatino und 14 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Ministero della Salute

Zitieren

APA

Sabatino, G., Fanelli, D., Cocchioni, M., Piccinini, C., Rosa, F. D., Guidoboni, M., Granato, A., Pancisi, E., Carloni, S., Azzali, I., Renzi, L., Ancarani, V., Petrini, M., Ridolfi, L., & Bulgarelli, J. (2024). 159P Unveiling the impact of DC vaccination on systemic immunity in advanced malignant melanoma: Preliminary results from the ABSIDE study. Immuno-Oncology and Technology, 24, 100788. https://doi.org/10.1016/j.iotech.2024.100788

Vancouver

Sabatino G, Fanelli D, Cocchioni M, Piccinini C, Rosa FD, Guidoboni M, et al. 159P Unveiling the impact of DC vaccination on systemic immunity in advanced malignant melanoma: Preliminary results from the ABSIDE study. Immuno-Oncology and Technology. 2024;24:100788. doi:10.1016/j.iotech.2024.100788

BibTeX
@article{Sabatino2024,
  author = {Sabatino, G.N. and Fanelli, D. and Cocchioni, M. and Piccinini, C. and Rosa, F. De and Guidoboni, M. and Granato, A.M. and Pancisi, E. and Carloni, S. and Azzali, I. and Renzi, L. and Ancarani, V. and Petrini, M. and Ridolfi, L. and Bulgarelli, J.},
  title = {159P Unveiling the impact of DC vaccination on systemic immunity in advanced malignant melanoma: Preliminary results from the ABSIDE study},
  journal = {Immuno-Oncology and Technology},
  year = {2024},
  volume = {24},
  pages = {100788},
  doi = {10.1016/j.iotech.2024.100788}
}
Kostenlos starten →